| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737175.6.12.1777 |
| P698 | PubMed publication ID | 17181424 |
| P50 | author | Marc Valentí | Q56949369 |
| Eduard Vieta | Q20090640 | ||
| P2093 | author name string | Isabella Pacchiarotti | |
| Jose M Goikolea | |||
| Margarita García-Amador | |||
| Raul F Sanchez | |||
| P2860 | cites work | Maintenance therapy for bipolar disorder: current and future management options | Q40373746 |
| Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder | Q44513113 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia | Q44649979 | ||
| Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile | Q45052998 | ||
| Aripiprazole and neuroleptic malignant syndrome | Q45108549 | ||
| A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 | ||
| Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
| Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 | ||
| Adjunctive aripiprazole in treatment-resistant bipolar depression. | Q51789886 | ||
| Atypical antipsychotics in the treatment of mood disorders | Q57612899 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Consensus development conference on antipsychotic drugs and obesity and diabetes | Q34293049 | ||
| Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. | Q34375654 | ||
| Pharmacokinetics of aripiprazole and concomitant lithium and valproate | Q34376865 | ||
| Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia | Q34507860 | ||
| Aripiprazole: pharmacology, efficacy, safety and tolerability | Q34558285 | ||
| Mechanism of new antipsychotic medications: occupancy is not just antagonism | Q35558773 | ||
| Aripiprazole: in acute mania associated with bipolar I disorder | Q35747870 | ||
| Impact of atypical antipsychotics on quality of life in patients with schizophrenia | Q35936881 | ||
| The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review | Q36015766 | ||
| Bipolar mixed states and their treatment | Q36106765 | ||
| Atypical antipsychotics: newer options for mania and maintenance therapy | Q36158824 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1777-1783 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Role of aripiprazole in treating mood disorders | |
| P478 | volume | 6 |
| Q37831357 | Aripiprazole for the treatment of bipolar disorder: a review of current evidence |
| Q28478032 | Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature |
| Q34809427 | Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? |
| Q34529810 | Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania |
| Q37299210 | Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review |
| Q34994544 | Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q37429721 | Treating bipolar disorder in the primary care setting: the role of aripiprazole |
| Q41528294 | Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole |
| Q37665567 | Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis |
Search more.